TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

Posted by on Apr 2nd, 2025

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the stock.

TherapeuticsMD Stock Up 5.9 %

Shares of NASDAQ:TXMD opened at $0.98 on Tuesday. TherapeuticsMD has a one year low of $0.70 and a one year high of $2.44. The company has a 50-day simple moving average of $0.96 and a 200-day simple moving average of $1.24.

TherapeuticsMD Company Profile

(Get Free Report)

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.

See Also

Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.